Core Laboratories (CLB) Cash & Current Investments (2022 - 2025)
Core Laboratories' Cash & Current Investments history spans 4 years, with the latest figure at $22.7 million for Q4 2025.
- For Q4 2025, Cash & Current Investments rose 18.5% year-over-year to $22.7 million; the TTM value through Dec 2025 reached $22.7 million, up 18.5%, while the annual FY2025 figure was $22.7 million, 18.5% up from the prior year.
- Cash & Current Investments reached $22.7 million in Q4 2025 per CLB's latest filing, down from $25.6 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $31.2 million in Q2 2025 to a low of $14.9 million in Q1 2024.
- Average Cash & Current Investments over 4 years is $20.7 million, with a median of $20.3 million recorded in 2024.
- Peak YoY movement for Cash & Current Investments: tumbled 32.47% in 2024, then surged 76.25% in 2025.
- A 4-year view of Cash & Current Investments shows it stood at $15.4 million in 2022, then fell by 2.0% to $15.1 million in 2023, then increased by 26.7% to $19.2 million in 2024, then grew by 18.5% to $22.7 million in 2025.
- Per Business Quant, the three most recent readings for CLB's Cash & Current Investments are $22.7 million (Q4 2025), $25.6 million (Q3 2025), and $31.2 million (Q2 2025).